chr7-92447889-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000287957.5(GATAD1):c.160G>A(p.Gly54Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,275,386 control chromosomes in the GnomAD database, including 8,931 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G54D) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000287957.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATAD1 | NM_021167.5 | c.160G>A | p.Gly54Ser | missense_variant | 1/5 | ENST00000287957.5 | NP_066990.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD1 | ENST00000287957.5 | c.160G>A | p.Gly54Ser | missense_variant | 1/5 | 1 | NM_021167.5 | ENSP00000287957 | P1 | |
GATAD1 | ENST00000644160.1 | n.16G>A | non_coding_transcript_exon_variant | 1/2 | ||||||
GATAD1 | ENST00000645746.1 | c.160G>A | p.Gly54Ser | missense_variant, NMD_transcript_variant | 1/6 | ENSP00000493785 |
Frequencies
GnomAD3 genomes AF: 0.104 AC: 15848AN: 151870Hom.: 873 Cov.: 33
GnomAD3 exomes AF: 0.171 AC: 1200AN: 7038Hom.: 79 AF XY: 0.174 AC XY: 599AN XY: 3448
GnomAD4 exome AF: 0.119 AC: 133478AN: 1123410Hom.: 8060 Cov.: 31 AF XY: 0.119 AC XY: 64158AN XY: 537894
GnomAD4 genome AF: 0.104 AC: 15852AN: 151976Hom.: 871 Cov.: 33 AF XY: 0.104 AC XY: 7694AN XY: 74328
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 2B Benign:4
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Phosphorus, Inc. | Aug 01, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Jul 28, 2017 | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 18, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 19, 2012 | p.Gly54Ser in Exon 01 of GATAD1: This variant is not expected to have clinical s ignificance because it has been identified in 9.4% (282/2994) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs10281879). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 10, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at